C. Coffey

发表

Down-modulation of high-affinity receptors for erythropoietin on murine erythroblasts by interleukin 3.

J. Nicholls, J. Fraser, F. Lin, 1988, Experimental hematology.

Assessment of heterogeneity and disease onset in the Parkinson's Progression Markers Initiative (PPMI) cohort using the Î±-synuclein seed amplification assay: a cross-sectional study

Yian Ma, D. Galasko, J. Seibyl, 2023, medRxiv.

TGF- β POLYMORPHISMS AND CARDIAC ALLOGRAFT REJECTION 1

R. Benza, H. Grenett, J. Tallaj, 2009 .

Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay

C. Adler, B. Mollenhauer, J. Eberling, 2023, Annals of clinical and translational neurology.

Evaluation of ATNPD framework and biofluid markers to predict cognitive decline in early Parkinson's disease

A. Toga, J. Phillips, D. Galasko, 2023, medRxiv.

Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor PD Progression

Alyssa, E. Tolosa, D. Galasko, 2023, medRxiv.

Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study

Michele T. M. Hu, Yen F. Tai, Z. Mari, 2023, Movement disorders clinical practice.

Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

C. Tanner, J. Seibyl, Douglas Galasko, 2023, The Lancet Neurology.

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

C. Tanner, A. Siderowf, T. Foroud, 2023, npj Parkinson's Disease.

Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.

C. Tanner, Douglas Galasko, A. Siderowf, 2023, Journal of Parkinson's disease.

Effects of AFQ056 on language learning in fragile X syndrome

Lauren E. Ethridge, W. Kaufmann, J. Veenstra-VanderWeele, 2023, The Journal of clinical investigation.